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Theoretically, the degree of 18F-FDG uptake in the glandular
tissues of the normal breast can affect the detection of breast
cancer. The aim of this prospective study was to investigate
relationships among age, menopausal state, and breast den-
sity and determine whether they affect 18F-FDG uptake in nor-
mal glandular breast tissue. Methods: Among 250 newly
diagnosed breast cancer patients, 149 patients (mean age 6
SD, 50.9 6 9.70 y; range, 32–77 y) were analyzed because
they had normal contralateral breasts confirmed by MRI,
mammography, and 18F-FDG PET examinations. PET images
were acquired 60 6 2 min after the administration of 18F-FDG
(5.2 MBq/kg of body weight). The maximum and average
standardized uptake value (SUVmax and SUVavg, respec-
tively) of 18F-FDG were calculated in the normal breast. Pa-
tients were divided into groups according to qualitative
breast density and menopausal state. Descriptive statistics
and 2-factorial analysis of covariance were used to assess
the effects of qualitative breast density, menopausal state,
and age on SUVmax and SUVavg. Pearson x2 was used to
test the relationship between menopausal state and qualita-
tive breast density. Results: The average age of patients
with nondense breasts was significantly higher than that of
patients with dense breasts (P , 0.01). Also, breast density
related to menopausal state (P , 0.05). Dense breasts had
an average SUVmax of 1.243 and mean SUVavg of 0.694,
whereas nondense breasts had a mean SUVmax of 0.997
and mean SUVavg of 0.592. Analysis of covariance indicated
that density and the linear effect of age were significant with
regard to both SUVmax and SUVavg. After removing the linear
effect of age, menopausal state had no effect on SUVmax
and SUVavg. Conclusion: 18F-FDG uptake significantly
decreases as age increases and breast density decreases.
Age and qualitative breast density are independent factors
and significantly affect 18F-FDG uptake for both SUVmax and
SUVavg. Menopausal state had no effect on SUVmax and
SUVavg.
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Breast cancer is the most common cancer among
women. Its incidence has also increased in recent decades,
with reduction in mortality due to early detection, screening
mammography, and introduction of adjuvant therapy.
Nevertheless, breast cancer continues to be the second
leading cause of cancer-related mortality in women, with
estimates of 182,460 diagnosed cases and 40,480 deaths
from the disease during 2008 for the United States (1).
Physical examination, together with conventional mam-
mography, is a sensitive method for the early detection of
breast cancer (2–4) and has been shown to decrease asso-
ciated mortality (5,6). Mammography, however, has limita-
tions in clinical practice; it has a low positive predictive value
of 35.8% as a screening test and is moderately sensitive for
detecting breast lesions (7). Also, the sensitivity for detecting
breast cancer declines significantly with increasing breast
density (7,8). High false-positive rates have been reported in
mammography of dense breasts (9), with a sensitivity of
30%268% in women with dense to extremely dense breasts
(3,8,10). An association of breast density and breast cancer
risk was first proposed by Wolfe (11), was confirmed by
others (12–14), and led to the acceptance of breast density as
an independent risk factor for breast cancer.
Other imaging modalities, such as CT and MRI, have
a high sensitivity but low specificity in diagnosing breast
cancer (15). MRI is less specific than conventional scinti-
mammography used for the detection of nonpalpable breast
lesions, and a recent meta-analysis (16) suggests that
scintimammography may be a useful adjunct to mammog-
raphy and physical examination in the diagnosis of breast
cancer.
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18F-FDG PET provides a high contrast between normal
and malignant tissues because malignant tissue is hyper-
metabolic. This is a major advantage and makes this
technique particularly valuable in the evaluation of dense
breasts for malignancy, because breast density has been
shown to decrease the sensitivity of mammography.
18F-FDG PET has been shown to be highly accurate in
characterizing palpable breast lesions and superior to other
modalities in detecting locoregional spread and distant
metastasis (17–22). As with mammography, higher 18F-
FDG uptake in normal breast tissue can affect the accuracy
of 18F-FDG PET in the detection of breast cancer.
To our knowledge, there is little information in the
literature for assessing factors that affect 18F-FDG uptake
in normal breast tissue such as age, menopausal state, and
the mammographic density in a systematic manner. Varia-
tion in age and breast density over time are important
factors to consider (23,24) when screening and monitoring
parenchymal changes with prophylactic and therapeutic
interventions. Therefore, we prospectively and systemati-
cally investigated the effect of age, menopausal status, and
mammographic density on 18F-FDG uptake in normal
glandular breast tissue.
MATERIALS AND METHODS
Patient Population
We conducted at the University of Pennsylvania a prospective
analysis of the role of 18F-FDG PET in the identification of breast
cancer. This prospective National Institutes of Health (NIH)–
funded program was designed to test the role of various radiologic
modalities including 18F-FDG PET for the detection and staging
of primary breast cancer. For the purpose of investigating age-
related changes and the effect of density and menopausal state, we
included women with normal contralateral breasts, excluding
those with suggestive findings on MRI, ultrasonography, or digital
mammography in the contralateral breast.
Two hundred fifty patients with breast cancer newly diagnosed
on film-screening mammography, ultrasonography, MRI, and
biopsy of the breast lesions were included in this study. This
study was compliant with the Health Insurance Portability and
Accountability Act and received Institutional Review Board
approval. Informed consent was obtained from the patients who
were enrolled in this study. No participant received chemotherapy
or radiation therapy before undergoing PET scans for preoperative
staging.
18F-FDG PET
Patients fasted for at least 4 h before the PET scan and had
blood glucose levels less than 140 mg/dL at the time of injection.
PET was initiated approximately 60 6 2 min after intravenous
administration of 18F-FDG (5.2 MBq/kg of body weight) through
an indwelling catheter inserted into an antecubital vein. PET was
obtained as a whole-body image, which included the entire trunk
(from the neck to the groin) on all patients, using a dedicated
whole-body PET scanner (Allegro; Philips Medical System).
Using a 137Cs point source, we obtained transmission scans to
provide attenuation correction. The images were reconstructed
using an iterative reconstruction algorithm. The ordered-subsets
expectation maximization method was used to reconstruct the
images for clinical and research analyses (25).
Image Analysis
After image reconstruction, a region of interest (ROI) was
carefully drawn on the normal breast around the glandular breast
tissue as determined by visual inspection on the consequent 4–6
PET scan slices. From these ROIs, the standardized uptake value
(SUV) was calculated according to the following formula:
MeanROI activity ðMBq=gÞ
Injected dose ðMBqÞ=bodyweight ðgÞ:
The maximum SUV (SUVmax) and the average SUV (SUVavg)
of 18F-FDG of the normal glandular breast tissue were measured
from the ROI, which was placed around the normal dense tissue in
the breast as visualized on the PET scan slice. The intended
SUVmax and SUVavg were generated from the image plane that
revealed the highest SUV. The nipple and areola area were excluded
from ROI placement. Two experienced nuclear medicine physicians
independently measured SUV.
Breast density for all patients was classified according to
mammography categories into 1 of 4 groups as defined by the
Breast Imaging Reporting and Data System: almost entirely fatty
(group 1), scattered fibroglandular tissue (primarily fatty) (group
2), heterogeneously dense (group 3), and extremely dense (group
4). Because we had few numbers of entirely fatty and extremely
dense breasts, we combined groups 1 and 2 as a nondense breast
group and combined groups 3 and 4 as a dense breast group. Also,
patients were categorized into 2 groups according to their
menopausal state: premenopausal or postmenopausal. We then
compared and analyzed SUVmax and SUVavg of the right and left
breasts to determine whether there was a difference between 18F-
FDG uptake of the right and left breasts.
Statistical Analyses
The data were summarized using descriptive statistics. A
Student t test of independent samples was used to compare mean
differences of age between dense and nondense breasts. An
analysis of covariance appropriate for a 2-factorial design was
applied to assess the effects of breast density and menopausal state
on SUVmax and SUVavg, adjusting for covariate age. After the
significant linear effect of age on the uptake values was de-
termined, separate simple linear regression analyses were per-
formed to further examine the relationship between age and
uptake values.
Pearson x2 was used to test the association between meno-
pausal state and density. Unless otherwise stated, all tests were
conducted using a type I error rate (a) of 0.05. Because of missing
observations, the number of cases included in different tests
varied. All analyses were performed using SPSS (version 13.0;
SPSS, Inc.) statistical software.
RESULTS
Of the 250 patients who were enrolled this study, 101
patients who had suggestive findings on radiologic exam-
inations in the contralateral breasts were excluded from the
analyses. Mean, SD, and minimum and maximum age for
the 149 patients with confirmed normal breasts were 50.9,
9.7, and 32 and 77 y, respectively. Estimates for SUVmax
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were 1.16, 0.33, 0.50, and 2.30, respectively, and estimates
for SUVavg were 0.67, 0.20, 0.30, and 1.20, respectively.
Breast Density, Menopausal State,
and Age Relationships
Mean and SD of ages of the 92 patients with dense
breasts were 49.0 6 8.67 y, and those of the 57 patients
with nondense breasts were 54.0 6 10.51 y. The average
age of patients with nondense breasts was significantly
higher than that of patients with dense breasts (P , 0.01).
Similarly, mean and SD of ages of the 81 premenopausal
patients were 44.2 and 5.7 y, and estimates of the 68
postmenopausal patients were 58.8 and 7.1 y. Average age
of postmenopausal patients was significantly higher (P ,
0.01) than that of premenopausal patients.
As the result of the relationships between age and
menopausal state, breast density related to menopausal
state (P , 0.05).
Relationship of SUV to Breast Density, Age,
and Menopausal State
Because breast density, age, and menopausal state were
related, analyses of covariance appropriate for a 2-factorial
design were applied to maximum and SUVavg classified by
density and menopausal states and adjusted for covariate
age. Analysis of covariance and least squares means,
corrected for age differences, are given in Tables 1 and 2,
respectively, for SUVmax, and in Tables 3 and 4, re-
spectively, for SUVavg.
The analysis of covariance indicated that the effect of
density and the linear effect of age were significant on
SUVmax. Dense breasts had an average of 1.243 SUVmax,
and nondense breasts had only 0.997 SUVmax. After
removing the linear effect of age, menopausal state had
no effect on SUVmax. Again, after removing the linear
effect of age, the interaction effect of breast density and
menopausal state was not significant, indicating the in-
dependence of their effect on SUVmax.
Linear effect of age on SUVmax was further investigated
using linear regression analysis. Simple linear regression
analysis estimates that average SUVmax decreases 0.011
units each year (P , 0.01) (Fig. 1).
The analysis of covariance indicated that breast density
and linear effect of age significantly affected SUVavg.
Dense breasts had a mean of 0.694 for SUVavg, and
SUVavg for nondense breasts was 0.592. After removing
the linear effect of age, menopausal state had a nonsignif-
icant effect on SUVavg. Again, after removal of the linear
effect of age, the interaction effect of breast density and
menopausal state was not significant, indicating their in-
dependence on SUVavg. Linear effect of age on SUVavg
was further investigated using linear regression analysis.
Simple linear regression analysis has shown that, on the
TABLE 1. Analysis of Covariance of SUVmax
Source
Sum of
squares
Degree of
freedom
Mean
square F Significance
Age (covariate) 1.466 1 1.466 16.323 0.000
Density 1.795 1 1.795 19.995 0.000
Menopausal
state
0.003 1 0.003 0.036 0.850
Density*
menopausal
state
0.036 1 0.036 0.402 0.527
Error 11.673 130 0.090
Total 14.973 134
*Levene’s test of homogeneity of variances; F 5 2.437,
P . 0.05.
TABLE 2. Means of SUVmax for Different Menopausal
States and Densities
Density Menopausal state Mean* SE
Dense Premenopausal 1.260 0.050
Postmenopausal 1.227 0.057
Mean 1.243 0.033
Nondense Premenopausal 0.979 0.072
Postmenopausal 1.016 0.071
Mean 0.997 0.044
*Covariate age in model is evaluated at average value of
50.88.
TABLE 3. Analysis of Covariance of SUVavg
Source
Sum of
squares
Degree of
freedom
Mean
square F Significance
Age (covariate) 0.517 1 0.517 15.884 0.000
Density 0.174 1 0.174 5.349 0.023
Menopausal
state
0.024 1 0.024 0.729 0.395
Density*
menopausal
state
0.026 1 0.026 0.810 0.370
Error 2.928 90 0.033
Total 3.669 94
*Levene’s test of homogeneity of variances; F 5 2.096,
P . 0.05.
TABLE 4. Means of SUVavg for Different Menopausal
States and Densities
Density Menopausal state Mean* SE
Dense Premenopausal 0.678 0.036
Postmenopausal 0.710 0.036
Mean 0.694 0.023
Nondense Premenopausal 0.538 0.062
Postmenopausal 0.647 0.051
Mean 0.592 0.035
*Covariate age in model is evaluated at average value of
50.88.
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average, SUVmax decreases 0.008 units each year (P ,
0.01) (Fig. 2).
There was no disagreement in the SUVmax calculated by
the 2 investigators. However, there were minor differ-
ences—resolved by consensus between the 2 operators—
with regard to SUVavg. There was no difference between
18F-FDG uptakes of right and left breasts of the different
density groups.
DISCUSSION
We have published the preliminary results of this study in
a review article (26). We have investigated the relationships
between 18F-FDG uptake and age, breast density, and
menopausal state. Vranjesevic et al. (27) retrospectively
analyzed the effects of breast density on 18F-FDG uptake in
45 women with normal breast tissue. Theirs was the first
published report showing that breast density affects the
uptake of 18F-FDG and that the SUVs are significantly
higher in dense breasts than in fatty breasts. We concur
with their findings; however, our findings on the effect of
menopausal state on SUV were contrary to their findings.
Vranjesevic et al. (27) observed that hormonal status was
a predictive variable in their stepwise multiple regression
analyses, whereas our covariance analyses, using age as the
covariate and after the elimination of the linear effect of
age, revealed that menopausal state alone had no effect on
SUV. The difference in conclusions could have been the
result of the relationship between age and menopausal
state. Once the linear effect of age is removed, as is done in
our covariance analysis, there might be little variability for
the menopausal state to explain.
FIGURE 1. Simple linear regression of
SUVmax with age.
FIGURE 2. Simple linear regression of
SUVavg with age.
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In another study (28), the authors reported that age and
menopausal status had not emerged as significant predictors
for 18F-FDG uptake using stepwise multiple regression
analyses. In our study, age was a statistically significant
predictor for SUV, perhaps because of the differences in the
sizes of samples (96 vs. 149 in our study). Their results
regarding the effect of breast density were in line with
previously published and present studies (27,29,30).
The results of our analyses showed that the average age
of patients with nondense breasts was significantly higher
than that of patients with dense breasts (P , 0.01) (Fig. 3).
The average age of postmenopausal patients was signifi-
cantly higher than that of premenopausal patients. As the
result of the relationships between age and menopausal
state, qualitative breast density related to the menopausal
state (P , 0.05). After removal of the linear effect of age,
menopausal state had no effect on SUVmax and SUVavg.
In other words, age and qualitative breast density are
independent factors and significantly affect 18F-FDG up-
take for both SUVmax and SUVavg.
Our data demonstrated that there is a significant decrease
of 18F-FDG uptake as age increases. To our knowledge, this
is the first study that shows a statistically significant
correlation between age and 18F-FDG uptake in the breast
tissue. The radiographic data in our study population
further confirmed those of previous studies in the mam-
mography literature, which showed older women tend to
have fatty breasts. Younger women tend to have denser
breasts than do older women (31–34). Therefore, we were
able to demonstrate that the 18F-FDG uptake in the breast
decreases with age, contradicting the results of the study by
Vranjesevic et al. (27). In addition, qualitative breast
density is considered an independent risk factor for breast
cancer (11–13). We have recently presented (35) our
investigation about the effect of qualitative breast density
on washing out of 18F-FDG from normal breast tissue.
According to this other report, the SUVmax and SUVavg
results between the 2 groups (dense and nondense breasts)
were statistically significant, but the percentage change
over time was not. To our knowledge, this is also the first
report of dual-time-point changes in normal breast tissue
regarding density. The change of 18F-FDG uptake does not
depend on the density of the breast. This finding is
especially important for malignancies in dense breasts, in
which the 18F-FDG uptake in the tumor increases with
time, whereas uptake decreases in normal breast tissue
regardless of density, improving the contrast resolution
between the tumor and the surrounding background activ-
ities.
According to our results in the present study, menopausal
state has no effect on 18F-FDG uptake after removal of the
linear effect of age. In the study by Vranjesevic et al. (27),
the authors reported that the breasts of premenopausal
women had a higher SUV than did the breasts of post-
menopausal women not receiving hormonal therapy. In
contrast, postmenopausal women receiving hormonal ther-
apy had SUVs similar to those of the premenopausal
women. Thus, the authors concluded that hormonal therapy
in postmenopausal women appears to normalize the glu-
cose metabolic activity of normal breast tissue. They found
these results by analyzing 36 subjects, 12 in each category.
In our study, we had no patients who were receiving
hormonal therapy, so we could not confirm these findings.
However, in the literature (36,37), hormone replacement
therapy or hormonal stimuli has been shown to increase
qualitative breast density. Therefore, we believe that further
studies are necessary with postmenopausal patients who are
on hormone therapy to determine the combined effect of
age and this therapeutic intervention.
An additional different result in the study by Vranjesevic
et al. (27) was that 18F-FDG uptake was slightly, but
significantly, higher in the right breast than in the left
breast. On average, they found that the metabolic activity in
the left breast was about 10% lower than that in the right
breast. Our study of 149 subjects showed no significant
difference in 18F-FDG uptake between right and left
breasts.
In our study and that of Vranjesevic et al. (27), the
measurements were stable and the interobserver variability
was low, emphasizing the excellent reproducibility.
We did not adjust the SUVs for lean body mass or total
body surface area because the corrected and uncorrected
SUVs were shown to be highly correlated by a regression
analysis in the study by Vranjesevic et al. (27). Thus, there
is likely no need to correct for lean body mass when
analyzing normal breast tissue, because the 18F-FDG
SUVavg in these tissues generally is below 1.0.
FIGURE 3. (A) Axial and sagittal images of subject with
mammographically nondense breasts. Measured SUVmax
and SUVavg of glandular tissue were 0.8 and 0.5, re-
spectively. (B) Axial and sagittal images of subject with
mammographically dense breasts. Measured SUVmax and
SUVavg of breast are 1.4 and 1.0, respectively. Difference
between degrees of 18F-FDG uptake is also visually
apparent on these images.
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CONCLUSION
Our data clearly demonstrated that the age of the subject
and the density of the breast are independent and important
factors in 18F-FDG uptake in normal breast tissue. There
was a statistically significant decrease in 18F-FDG uptake
as the age increased. Although the younger, premenopausal
patients or the patients with dense breasts have higher
SUVs, the accuracy of 18F-FDG PET studies in diagnosing
malignant breast tumors may not be significantly affected
because of the high contrast between the tumor and the
surrounding uptake of this radiotracer. Our findings repre-
sent functional data regarding changes in breast tissue
metabolic activity with aging—data that may become
important as imaging techniques are used to monitor new
prophylactic and therapeutic interventions including novel
hormonal and pharmacologic entities.
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